We are live on ! Find out more
FLC

Fifth Lane Capital Portfolio holdings

AUM $1.63M
1-Year Est. Return 7.5%
This Fund
S&P 500
This Quarter Est. Return
+11.92%
1 Year Est. Return
+7.5%
3 Year Est. Return
+79.98%
5 Year Est. Return
10 Year Est. Return
AUM
$192M
AUM Growth
+$33.1M
Cap. Flow
+$36.3M
Cap. Flow %
18.93%
Top 10 Hldgs %
70.32%
Holding
475
New
116
Increased
20
Reduced
19
Closed
248

Similar funds

Fifth Lane Capital's Q3 2022 Portfolio in Review

As of Q3 2022, Fifth Lane Capital held 475 positions worth $192M, up 21% from $159M the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Fifth Lane Capital deployed $36.3M of net new capital in Q3 2022, opening 116 new positions and adding to 20 existing holdings. Its largest new stake was Biohaven Pharmaceutical Holding Company Ltd.: 140,000 shares worth $21.2M.

By sector, the portfolio is most concentrated in Technology at 39% of assets, up from 14% a quarter earlier, followed by Healthcare and Real Estate.

On the sell side, the largest reduction was Churchill Capital Corp VII Class A Common Stock, an estimated $517K trimmed.

  • Fifth Lane Capital's largest Q3 2022 buy was Biohaven Pharmaceutical Holding Company Ltd.: 140,000 shares worth $21.2M.
  • Fifth Lane Capital added most to Citrix Systems Inc in Q3 2022, an estimated $33M increase.
  • Fifth Lane Capital's biggest Q3 2022 reduction was Churchill Capital Corp VII Class A Common Stock, cutting an estimated $517K.
  • Fifth Lane Capital fully exited SailPoint Technologies Holdings, Inc. Common Stock in Q3 2022, selling an estimated $6.89M.
  • Fifth Lane Capital's ten largest holdings make up 70% of its $192M portfolio in Q3 2022.
  • Fifth Lane Capital opened 116 new positions and closed 248 in Q3 2022.
  • Fifth Lane Capital's portfolio value rose 21% quarter-over-quarter to $192M.

Based on Fifth Lane Capital's 13F filing for Q3 2022, filed 14 Nov 2022.